ArticleNature communications2022
AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis.
Dae Gyu Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleNature communications2022
Dae Gyu Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.